id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
ybljtOtREemXSyc0lz5mvg,b53nbDmi,https://europepmc.org/articles/PMC5026174/,MLE,"o stages for the control is Z
0,","=t
0
X
0+(1 − t
0)Y
0 and simila",TextQuoteSelector,TextPositionSelector,20073,20076,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-10T11:33:31.809840+00:00
l9SA1utREemGqqfHMXPM9Q,b53nbDmi,https://europepmc.org/articles/PMC5026174/,colorectal cancer,n 2 and treatment selection for , 3. Regulatory guidance dealing ,TextQuoteSelector,TextPositionSelector,8728,8745,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-10T11:32:08.129928+00:00
kRxcjOtREem1Rkuy-m1Cxw,b53nbDmi,https://europepmc.org/articles/PMC5026174/,acute myocardial infarction,"structive pulmonary disorder 1, ", 2 and treatment selection for c,TextQuoteSelector,TextPositionSelector,8670,8697,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-10T11:31:56.865399+00:00
iBs4nOtREem606O3DxwsMw,b53nbDmi,https://europepmc.org/articles/PMC5026174/,chronic obstructive pulmonary disorder,tice include dose selection for ," 1, acute myocardial infarction ",TextQuoteSelector,TextPositionSelector,8628,8666,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-10T11:31:41.720314+00:00
YytbputSEemz2mN9oaXerQ,b53nbDmi,https://europepmc.org/articles/PMC5026174/,Anxiety,n the Hamilton Rating Scale for ,) are normally distributed with ,TextQuoteSelector,TextPositionSelector,78547,78554,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-10T11:37:49.289024+00:00
WswXhOtSEemEkmubIyhSpA,b53nbDmi,https://europepmc.org/articles/PMC5026174/,generalised anxiety disorder, a placebo for the treatment of ,. We assume that the outcomes (t,TextQuoteSelector,TextPositionSelector,78439,78467,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-10T11:37:35.140759+00:00
NCfgIutSEemspZ8FYkK6uw,b53nbDmi,https://europepmc.org/articles/PMC5026174/,CHN,"mance of the Kimani et al. (D
1,","), naïve (D
1,MLE) and stage 2 (",TextQuoteSelector,TextPositionSelector,58292,58295,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-10T11:36:30.407295+00:00
